- Home
- JMIA vs IMNM Comparison
JMIA vs IMNM Comparison
Compare JMIA & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMIA
- IMNM
- Stock Information
- Founded
- JMIA 2012
- IMNM 2006
- Country
- JMIA Germany
- IMNM United States
- Employees
- JMIA N/A
- IMNM N/A
- Industry
- JMIA Catalog/Specialty Distribution
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- JMIA Consumer Discretionary
- IMNM Health Care
- Exchange
- JMIA Nasdaq
- IMNM Nasdaq
- Market Cap
- JMIA 573.4M
- IMNM 585.5M
- IPO Year
- JMIA 2019
- IMNM 2020
- Fundamental
- Price
- JMIA $3.70
- IMNM $9.99
- Analyst Decision
- JMIA Buy
- IMNM Strong Buy
- Analyst Count
- JMIA 2
- IMNM 5
- Target Price
- JMIA $8.00
- IMNM $28.60
- AVG Volume (30 Days)
- JMIA 2.5M
- IMNM 881.8K
- Earning Date
- JMIA 02-13-2025
- IMNM 11-13-2024
- Dividend Yield
- JMIA N/A
- IMNM N/A
- EPS Growth
- JMIA N/A
- IMNM N/A
- EPS
- JMIA N/A
- IMNM N/A
- Revenue
- JMIA $181,204,000.00
- IMNM $10,129,000.00
- Revenue This Year
- JMIA $2.77
- IMNM N/A
- Revenue Next Year
- JMIA $5.62
- IMNM N/A
- P/E Ratio
- JMIA N/A
- IMNM N/A
- Revenue Growth
- JMIA 3.61
- IMNM N/A
- 52 Week Low
- JMIA $2.89
- IMNM $8.97
- 52 Week High
- JMIA $15.04
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- JMIA 40.95
- IMNM 40.28
- Support Level
- JMIA $3.60
- IMNM $9.24
- Resistance Level
- JMIA $3.88
- IMNM $11.06
- Average True Range (ATR)
- JMIA 0.18
- IMNM 0.74
- MACD
- JMIA -0.02
- IMNM -0.06
- Stochastic Oscillator
- JMIA 14.18
- IMNM 31.78
About JMIA Jumia Technologies AG each representing two
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.